Does a Blue Ribbon Make This Biotech Stock a Buy Now?

Does a Blue Ribbon Make This Biotech Stock a Buy Now?

Source: 
Motley Fool
snippet: 

An experimental cancer pill from Loxo Oncology (NASDAQ:LOXO) is getting heaps of attention going into one of biotech's most important scientific conferences this year. The American Society of Clinical Oncology recently released details from of heaps of drug trials that will be presented at the meeting, and investors thrilled with this company's candidate drove the stock higher overnight.